Category: News

CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, today confirms that it has received both regulatory approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and favourable ethical opinion from a UK Research Ethics Committee (REC) to initiate its open […]

ChemoSeed is a bioresorbable implant to provide a drug delivery system for the treatment of tumours, whilst avoiding the unwanted side effects associated with current treatments. Constructed from a polylactic-co-glycolic acid polymer, each ChemoSeed measures 6mm in length and 2mm in diameter. In its first indication, high grade glioma (HGG), the number of seeds implanted […]

Media hype about medical innovations tends to focus on new therapies emerging from laboratories and clinical trials. Sadly, many breakthroughs fail to achieve optimal results in the real world, for reasons ranging from poor adherence by their patients, to drug formulations that may bias against atypical users, from children to people with stroke.